|
Scientific Advisory Board
Professor Paul A. Wender
Bergstrom Professor of Chemistry, Department of Chemistry,
Stanford University
Dr. Paul A. Wender is Bergstrom Professor of Chemistry at Stanford University
and is
recognized as a world-leader in the field of drug transport research. Paul has
been especially active in elucidating drug delivery and novel mechanisms of transport
into cells, areas that are at the cutting-edge of contemporary drug development.
Professor Wender obtained his Ph.D. from Yale University in 1973 and embarked
upon a career in which he has excelled in complex molecule synthesis and addressing
problems of medical significance. He has been the recipient of numerous awards
for his elegant research including ICI Pharmaceutical Group's Stuart Award for
Excellence in Chemistry, 1988, Pfizer Research Award for Synthetic Organic Chemistry,
1995, American Chemical Society Award for Creative work in Synthetic Organic
Chemistry, 1998, H.C. Brown Award for Creative Research, as well as numerous
teaching awards. In recognition of his accomplishments which span the fields
of chemistry, biology and medicine, Paul was elected a Member of the National
Academy of Science in 2003.
Professor Stephen Hanessian, F.R.S.C., O.C.
Isis Pharmaceuticals Research Chair, Department of
Chemistry, University of Montreal
Dr. Stephen Hanessian is McConnell Professor of Chemistry at
the University of Montreal and holds the NSERCC Chair in Medicinal
Chemistry. Since 2000, Dr. Hanessian has, concurrently, been
active as an Adjunct Professor at the University of California,
Irvine. Steve has been internationally recognized for his innovative
contributions in the field of medicinal chemistry by many awards,
including the Wolfrom Award (American Chemical Society), the
1996 Canada Gold Medal for Science and Engineering (Canada's
highest award for scientific achievement), and has been made
an Officer of the Order of Canada. His prodigious output is
exemplified by principal inventorship in over 25 patents, authorship
on more than 400 papers, and the training of hundreds of scientists.
Steve’s knowledge of drug design, and the chemistry of
amino acids, peptides and mimics, as well as molecular recognition,
will directly impact Advanced Proteome Therapeutics’ objective
of establishing a pipeline of protein products to address diseases
that remain inadequately treated by existing therapeutics.
Professor Stephen G. Withers
Khorana Chair of Biological Chemistry, Chemistry
Department, University of British Columbia
Dr. Stephen G. Withers is Khorana Professor of Chemistry and
Biochemistry at the University of British Columbia, where he
holds joint appointments in the Department of Chemistry and
Department of Biochemistry and Molecular Biology. Dr. Withers
is internationally recognized for his research on enzyme mechanisms,
particularly enzymes that process oligosaccharides. His research
in this area has been recognized by the Corday Morgan Medal
of the Royal Society of Chemistry, U.K. (1989), the Merck Award
for Organic Chemistry and Biochemistry of the Canadian Society
for Chemistry (1989), the 2002 Whistler Award of the International
Carbohydrate Organization, and the Rutherford Medal of the
Royal Society of Canada (1993). Steve’s expertise in
the area of kinetics and mechanisms of enzyme action mesh well
with the capabilities required to achieve the mission of the
Company.
|
